BioMed Research International

BioMed Research International / 2014 / Article
Special Issue

Endothelium in Diseased States

View this Special Issue

Research Article | Open Access

Volume 2014 |Article ID 413629 |

Peter Slezak, Angelika Puzserova, Peter Balis, Natalia Sestakova, Miroslava Majzunova, Ima Dovinova, Michal Kluknavsky, Iveta Bernatova, "Genotype-Related Effect of Crowding Stress on Blood Pressure and Vascular Function in Young Female Rats", BioMed Research International, vol. 2014, Article ID 413629, 11 pages, 2014.

Genotype-Related Effect of Crowding Stress on Blood Pressure and Vascular Function in Young Female Rats

Academic Editor: Vladimir V. Matchkov
Received09 Dec 2013
Accepted27 Jan 2014
Published05 Mar 2014


This study investigated the influence of chronic crowding stress on nitric oxide (NO) production, vascular function and oxidative status in young Wistar-Kyoto (WKY), borderline hypertensive (BHR) and spontaneously hypertensive (SHR) female rats. Five-week old rats were exposed to crowding for two weeks. Crowding elevated plasma corticosterone and accelerated BP ( versus basal) only in BHR. NO production and superoxide concentration were significantly higher in the aortas of control BHR and SHR versus WKY. Total acetylcholine (ACh)-induced relaxation in the femoral artery was reduced in control SHR versus WKY and BHR, and stress did not affect it significantly in any genotype. The attenuation of ACh-induced relaxation in SHR versus WKY was associated with reduction of its NO-independent component. Crowding elevated NO production in all strains investigated but superoxide concentration was increased only in WKY, which resulted in reduced NO-dependent relaxation in WKY. In crowded BHR and SHR, superoxide concentration was either unchanged or reduced, respectively, but NO-dependent relaxation was unchanged in both BHR and SHR versus their respective control group. This study points to genotype-related differences in stress vulnerability in young female rats. The most pronounced negative influence of stress was observed in BHR despite preserved endothelial function.

1. Introduction

Stress is considered an etiological factor associated with the development of atherosclerosis and myocardial infarction as well as hypertension [13]. Research investigating mechanisms involved in stress-related cardiovascular disease and investigations concerning the roles of acute and chronic stress and their relation with the development of cardiovascular disease have attracted much attention [4]. However, despite this effort there are still ambiguous results concerning a causal association between stress and hypertension. Esler et al. [5, 6] concluded that mental stress is a cause of essential hypertension in humans; on the other hand, Sparrenberger et al. [7, 8] did not find psychosocial stress to be causally associated with hypertension. Discrepancies in results from human studies could arise from different stressors being considered, the intensity and duration of stress [9] and different populations investigated. Moreover, the age in which organism is exposed to aversive stimuli is another important factor. Regarding blood pressure (BP), many observations indicate that although the full manifestation of hypertension usually occurs later in life, its roots can be traced back to early ontogeny [10, 11]. One important period, common to both humans and rats, during which negative environmental factors affect later development of BP is the intrauterine period [11]. Additionally, data in animal studies indicate that the most important developmental window regarding BP after birth is between the sixth and eighth week of life in rats with a positive genetic predisposition to hypertension [12], that is, in the postweaning period, when rats have usually just been separated from the mother. The question, however, arises whether a given period of life might also be a critical window in subjects with a negative family history of hypertension or in those with a single hypertensive parent, and if stress acting at this age can accelerate an increase in their BP. As it is not possible to perform this kind of study in humans (i.e., to intentionally expose children to chronic stress and to control the duration and intensity of the stressor), we simulated such an experiment in rats using normotensive Wistar-Kyoto (WKY, both parents normotensive), spontaneously hypertensive (SHR, both parents hypertensive), and borderline hypertensive (BHR, mother hypertensive and father normotensive) rats. We used crowding as a stressor acting in the postweaning period. Although crowding is a relatively mild stressor, it has a considerable effect on the hypothalamic-pituitary-adrenal (HPA) axis and the sympathoadrenal system in adult rats [1315]. However, in addition to stress-activated systems there are several anti-stress systems including the L-arginine/nitric oxide (NO) system [16]. It has been shown that stress-related hormones and mediators may affect both vascular NO production and degradation, and thus its bioavailability [17]. We have shown previously that chronic crowding stress increased NO production in the aortas of adult normotensive WKY males, which was associated with improved acetylcholine-induced relaxation [18]. Thus, the L-arginine/NO system supposedly protects normotensive rats from developing stress-induced hypertension. However, elevated NO production per se might not imply better NO bioavailability, especially under conditions of oxidative stress, which was observed in hypertensive rats [19] as well during acute or chronic stress [15, 2023]. Additionally, it is of interest that despite significant sex-related differences in cardiovascular regulation [24], NO production [25], and stress-induced neuroendocrine and cardiovascular responses [26, 27], the majority of experimental studies have used male rats.

Thus, this study investigated the influence of crowding in postweaning WKY, BHR, and SHR female rats on the development of BP and NO-mediated vascular function. We hypothesize that exposure to crowding stress in the postweaning period could accelerate the development of hypertension in rats with a genetic predisposition to hypertension by altering oxidative status and/or NO production in the vascular system.

2. Material and Methods

2.1. Animals and Treatment

All rats, WKY, BHR, and SHR, were born in our certified animal facility in order to retain the same environmental background for all the rats. BHR were F1 offspring of SHR dams and WKY sires. After birth, the rats were kept together with their mother until the end of the fifth week of life. Then they were separated from the mother, divided according to sex, and females were randomly divided into the control and crowding-exposed group. Control rats were kept under standard conditions (more than 200 cm2/100 g of animal body weight) in groups of 4 rats per cage. Animals in the stress group were kept at five rats per cage and exposed to crowding stress, which was induced by reducing their living space to approximately 70 cm2 per 100 g of animal weight for two weeks. The precise size of the cages was adjusted using special cages with one flexible wall. This wall was moved to the appropriate position on the same days as the body weights of the rats were determined. All animals were maintained at an ambient temperature of 22 to 24°C under artificial light with a 12 h light/dark cycle during the whole experiment. The rats were fed a standard pellet food and had water and food ad libitum. The experiments were performed in accordance with European Community and NIH guidelines for the use of experimental animals and were approved by the State Veterinary and Food Administration of the Slovak Republic.

2.2. Blood Pressure and Heart Rate Measurements

Systolic blood pressure (BP) and heart rate (HR) were measured indirectly by tail-cuff plethysmography between 08.00 and 11.00 a.m. as was described in detail previously [15]. In order to minimize the influence of nonspecific stress on BP measurements, all rats were handled and accustomed to the tail-cuff procedure before experimentation. Each value was calculated as the average of five measurements. BP and HR values were measured at the beginning of the experiment (basal) and after the 1st and 2nd weeks of the experiment. Body weight (BW) was determined on the same days.

2.3. Plasma Corticosterone Measurements

Rats were sacrificed by decapitation after brief CO2 anesthesia between 07.30 and 09.30 a.m. [15]. Blood samples were collected in heparinized test tubes and immediately centrifuged at 850 g for 10 min at 4°C. Plasma samples were then stored at −80°C until analysis. Plasma corticosterone (pCort) was measured in duplicates using 20 μL of plasma with an enzyme immunoassay kit (Arbor Assays, Ann Arbor, MI, USA), according to the manufacturer’s instructions.

2.4. Vascular Reactivity Measurements

Femoral arteries were carefully dissected, immersed, and transferred to cold physiological salt solution (PSS) and then cleaned to remove the adipose and connective tissues [15]. Arterial segments (1.0 to 1.5 mm long) were mounted in a small vessel wire myograph (Dual Wire Myograph System 410A, DMT A/S, Aarhus, Denmark). Dissection, mounting, and normalization of each vessel were performed according to [28]. Femoral artery reactivity measurements were performed as described previously [15]. Briefly, the experimental protocol consisted of the following steps. (1) PSS in the myograph chamber was changed to KPSS (i.e., PSS in which NaCl was exchanged for an equimolar concentration of KCl 125 mmol/L) and contraction was measured. (2) Ten μmol/L of norepinephrine (NE) was added and the contraction plateau value was recorded. (3) The artery was preconstricted with serotonin (1 μmol/L). When the contraction of the artery was steady, increasing concentrations of the vasodilator acetylcholine (ACh, from 0.001 to 10 μmol/L) were added in a cumulative manner and the endothelium-dependent relaxation response curve was recorded. (4) The same experiment was repeated after 25 min preincubation with the NO synthase inhibitor -nitro-L-arginine methyl ester (L-NAME, 300 μmol/L) in the bath medium. (5) After serotonin preconstriction (1 μmol/L), the NO donor sodium nitroprusside ([29], SNP, 0.001 to 10 μmol/L) was added cumulatively and the relaxation response curve was recorded. (6) Finally, PSS was changed to KPSS and, after reaching the contraction plateau, NE (10 μmol/L) was added and the maximal contraction of the artery was recorded. The artery was washed out four times with PSS and stabilized for 20 min after each step. All concentrations were expressed as final concentrations in the myograph chamber. All chemicals used were purchased from Sigma-Aldrich (Germany) and Merck Chemicals (Germany).

2.5. Nitric Oxide Synthase Activity

NO synthase (NOS) activity was determined by [3H]-L-arginine conversion to [3H]-L-citrulline (MP Biomedicals, USA) in crude tissue homogenates of aorta, as described previously [15] and was expressed as pmol/min/mg of protein.

2.6. Superoxide Measurement

The assay was performed as described previously [30] with some modifications. The aortic rings were cut (10–15 mg), cleansed of connective tissue, and placed into ice cold PSS. Lucigenin (50 μmol/L) as well as tissue samples alone were added to PSS bubbled with pneumoxide (5% CO2 and 95% O2) at pH 7.4 and 37°C, and preincubated in the dark for 20 min. After preincubation, either background chemiluminescence or chemiluminescence produced by the aortic rings was measured for 6 min using a TriCarb 2910TR liquid scintillation analyzer (Perkin Elmer). Background counts were subtracted from values obtained from the samples. Results were expressed as counts per minute per mg of tissue (cpm/mg). All chemicals used were purchased from Sigma-Aldrich (Germany) and Merck Chemicals (Germany).

2.7. Statistical Analysis

Final body weight, heart rate and blood pressure, relative weight of the left ventricle and adrenal glands, normalized diameter, basal tension, and contraction data as well as the maximal response () and the concentration that produced a half maximal response (pD2) were analyzed using two-way ANOVA and Bonferroni post-hoc test. Differences between concentration response curves were assessed with two-way repeated measures ANOVA and vertical contrast using Bonferroni adjustment. The SNP-induced vasorelaxant data were fitted by four-parameter logistic function using GraphPad Prism 5.0 (San Diego, CA, USA). To determine the depression in relaxation at higher concentrations of ACh in the ACh dose-response curves, the maximal response to ACh and the responses at subsequent ACh concentrations were compared using Dunnett’s test (Figure 3). Because of the inherent non-normality of pCort data, these were analyzed using a generalized linear model (Gamma distribution, logarithmic link function in R v.2.15.0, All values (except for pCort) are presented as mean ± SEM. pCort data are presented as mean ±95% confidence interval. The significance level of all tests was set at 5% ().

3. Results

3.1. Basic Biometric, Cardiovascular, and Biochemical Parameters

There were significant differences in BW (Table 1) among the WKY, BHR, and SHR groups at the end of the experiment (F2,71 = 5.7; ). The effect of age on BW was significant in all groups investigated (main effect of age ). Stress reduced BW gain in general (F1,71 = 27.8, main effect of stress); however, a significant stress-related reduction in BW gain was observed only in BHR and SHR versus the respective control (Table 1).

Control Stress Control Stress Control Stress

BW basal (g)
BW final (g)
BW gain (g)
Final HR (bpm)
LVM/BW (mg/g)
AG/BW (mg/g)
1pCort (ng/mL)

Values represent mean ± SEM (except for pCort) of 8–14 rats. BW: body weight; HR: heart rate; LVM/BW: left ventricular mass-to-body weight ratio; AG/BW: adrenal gland-to-body weight ratio; pCort: plasma corticosterone; versus WKY respective group (control/stress); versus BHR respective group (control/stress); versus control group of the same genotype. 1Because of the inherent non-normality of pCort, these data were analyzed using a generalized linear model (Gamma distribution, logarithmic link function) and they are presented as mean ± 95% confidence interval.

Basal BP in 5-week WKY, BHR, and SHR rats was , , and  mmHg, respectively, and there were significant differences among the genotypes (F2,71 = 29.0; ). As the postweaning period was associated with body growth there were also significant age-related changes in BP (main effect of age ). Although stress did not affect BP significantly, there was a consistent trend toward increased BP in all crowded rats compared to controls (Figure 1). However, there was a significant effect of time (F2,71 = 9.6; ) and a time-strain interaction (F4,71 = 3.0; ). This analysis revealed nonsignificant time-related changes in BP in both WKY groups. In SHR, a significant elevation in BP was observed in both groups as compared to basal values (). In BHR, stress accelerated BP increase as opposed to the prestress value (), while no significant increase was seen in the control BHR (Figure 1). Regarding HR, there were significant genotype-related differences (F2,71 = 13.2, , main effect of genotype); however, age and stress failed to affect HR in all genotypes investigated (Table 1).

Plasma corticosterone concentration was significantly different among genotypes (), with the highest values observed in SHR rats (Table 1). Stress significantly increased pCort (, main effect of stress). Although we observed higher levels of pCort in all WKY, BHR, and SHR stressed rats than in their respective control groups, the difference was statistically significant only in BHR. Additionally, significant genotype-related differences in relative adrenal gland weight (AG/BW) were observed (F2,70 = 50.0; ). BHR and SHR, both the control and stress groups, had higher AG/BW ratios than the WKY groups but there was no significant effect of crowding (Table 1).

Under control conditions, relative left ventricular weights were significantly higher in SHR versus both WKY () and BHR, respectively (), and no effect of crowding was observed (Table 1).

Genotype and crowding had significant effects on NO synthase activity in the aorta: F2,30 = 18.2, , main effect of genotype; and F1,30 = 29.0, , main effect of stress. NOS activity was elevated significantly in both control BHR and SHR versus WKY, and stress increased NO production significantly in all genotypes investigated (Figure 2(a)).

Superoxide levels were also increased in control BHR and SHR versus WKY (F2,30 = 107; , main effect of genotype). In crowded BHR and SHR, superoxide levels were either unchanged () or reduced (), respectively, versus the respective control group; however, in SHR they were still significantly higher versus stressed WKY and BHR ( versus both) (Figure 2(b)).

3.2. Vascular Function

To investigate vascular function in the endothelium-intact femoral artery in individual genotypes as well as the effect of stress, we investigated normalized internal diameter and NE-, serotonin-, and KPSS-induced contractions as well as SNP-induced (Table 2) and ACh-induced relaxations (Table 2, Figures 3(a)3(f)).

Control Stress Control Stress Control Stress

ND ( m)
Basal tension (kPa)
NE—phasic (kPa)
NE—tonic (kPa)
Ser (kPa)
Ser—after L-NAME (kPa)
KPSS (kPa)
SNP (%)
SNP pD2 (−log(mol/L))
ACh (%)
ACh pD2 (−log(mol/L))

Values represent mean ± SEM of 7–12 rats. ND: normalized diameter of the femoral artery at 13.3 kPa; NE: norepinephrine (10  mol/L); Ser: serotonin (1  mol/L); L-NAME: NG-nitro-L-arginine methyl ester; KPSS: PSS in which NaCl was exchanged for an equimolar concentration of KCl; SNP: sodium nitroprusside; ACh: acetylcholine; versus WKY respective group (control/stress); versus BHR respective group (control/stress); versus control group of the same genotype; versus the same group before L-NAME.

There were significant differences in the normalized diameter (ND) between BHR and SHR in both the control and stress groups, but crowding did not affect it significantly (Table 2). Norepinephrine and serotonin induced contractile responses in the femoral arteries. NE induced biphasic responses: a transient contraction (early response, phasic contraction) was followed by a depression in response almost to baseline value followed by a sustained contraction (delayed response, tonic contraction). There were differences among the rat strains in both phasic (F2,48 = 10.6; ) and tonic (F2,48 = 9.3; ) contractions, with significantly higher values observed in control BHR and SHR versus WKY. However, a significant effect of crowding was only observed in tonic contraction of BHR, which was attenuated versus control BHR (Table 2). On the other hand, no differences in serotonin-induced contractions were observed among the groups either before or after L-NAME pretreatment. The response of the arteries to serotonin after pretreatment with L-NAME was augmented compared to responses before L-NAME administration (main effect of L-NAME; F1,92 = 25.7; ) and this effect was significant in both WKY groups as well as in the stressed BHR and SHR groups (Table 2).

Maximal KPSS-induced contraction (due to depolarization by K+) was not altered by crowding in any genotype versus its respective control group (Table 2).

Cumulative addition of exogenous NO donor SNP affected vasorelaxation similarly in all groups investigated. There were no differences in among the groups (Table 2). The sensitivity of the femoral arteries to SNP, determined as pD2, was significantly reduced in both SHR groups as compared to WKY and BHR (Table 2).

There were significant genotype-related differences in overall ACh-induced relaxation expressed as either ACh- (Table 2, F2,48 = 116; ) or the area under the ACh-induced dose-response curve (AUC) (Figure 4, F2,48 = 27; ); significant reductions were observed in SHR versus both WKY and BHR () for all comparisons. The main effect of stress on ACh- and AUC was not significant. The sensitivity of the femoral arteries to ACh, measured as ACh-pD2, was similar among the genotypes and stress failed to affect it compared to the control group of the same genotype. However, stress increased sensitivity to ACh in BHR and SHR versus stressed WKY (Table 2, F2,48 = 3.9; , effect of genotype-stress interaction).

Inhibition of NO synthase by L-NAME significantly reduced endothelium-dependent relaxations in all groups investigated (Figure 3). The NO-dependent component was reduced significantly in the young females with a genetic predisposition to high BP (F2,48 = 3.2; , main effect of genotype). On the other hand, the NO-independent component was significantly elevated in control BHR () while a reduction was seen in control SHR versus WKY (; Figure 4). In addition, maximal relaxation after acute L-NAME pretreatment was significantly reduced in control SHR (%) versus WKY (%, ).

There were significant differences in both the NO-dependent and NO-independent components of stressed WKY rats versus control (Figure 4). Crowding induced reduction of NO-dependent component of ACh-induced relaxation which was compensated by the elevation of NO-independent component in WKY, which was not observed in BHR and SHR (Figure 4).

4. Discussion

This study is the first to examine the effects of chronic stress on BP, superoxide, and NO production as well as vascular function in young normotensive, borderline hypertensive, and spontaneously hypertensive female rats in the postweaning period. Social stress produced by crowding, as described in this study, resulted in a generalized reduction in body weight gain as well as elevations in pCort and aortic NO production in all genotypes investigated. However, genotype-related differences in response to stress were observed in BP, superoxide concentration, and mechanism of vasorelaxation. Stress accelerated the increase in BP in BHR while no effect was observed in WKY and SHR. Vascular studies revealed overall endothelial dysfunction only in SHR, while normal endothelial function was seen in BHR. However, reduced NO-dependent relaxation was observed in both control BHR and SHR versus WKY. Interestingly, stress elevated superoxide concentration and reduced NO-dependent relaxation only in WKY, which was not observed in rats with elevated blood pressure.

This study was established to determine if stress acting in the postweaning period (i.e., in the period shortly after separation from the mother) can accelerate BP increases in rats. This developmental period was chosen as it is a critical developmental window in SHR rats [10]. Additionally, chronic noise, which can be considered a stressor, increased BP in 3-4 year-old children in kindergarten [31], that is, the period when children are usually separated from their mothers for the first time in their lives. The above-mentioned study suggested that exposure to stressful stimuli during the period of life when children are learning to be without maternal protection might negatively affect cardiovascular regulation. In addition, stress was shown to alter body weight, which might be expected to differ depending on the stressor, in humans [32, 33] and rats [34, 35]. In this experimental study, reduced age-related body mass gain and a consistent trend toward increasing BP was seen in all stressed groups. However, the most pronounced effect of stress was observed in rats with one hypertensive parent (mother in this case), in which pCort, body mass gain, and BP were all significantly affected. In SHR, the age-related increase in BP was similar in the control and stressed groups, despite reduced growth, suggesting that in this strain their genetic predisposition to hypertension is the dominant factor and stress does not alter BP under the given conditions.

This study showed that crowding is a mild but effective chronic stress model in postweaning female rats, similar to what we have shown previously in adult normotensive males [15, 18]. However, in this study we observed significant genotype-related differences in the activation of the HPA axis as determined by pCort concentration. In agreement with previously published studies, we observed a higher basal corticosterone concentration in young SHR animals compared to the WKY strain [36] but not in BHR [37]. Regarding the effect of stress, the main effect of crowding on pCort concentration was significant, but the most pronounced increase was observed in BHR, suggesting that young females of this genotype are particularly sensitive to this stressor. Insignificant increases in pCort in WKY and SHR rats (versus their respective control) at the end of the experiment can be explained by better adaptation, which protects organisms against detrimental effects of chronic stress. Adaptation to chronic stress has been observed in various stress models in humans as well as animals [38, 39], while an inability to adapt may result in diseased states. Similar to pCort, stress-induced elevation in BP was significant only in BHR. In agreement with this, other studies have shown higher pressor responses in adult BHR males to various stressors as compared to WKY [4042]. Interestingly, differences in pressor adaptation to stress were shown to be related to the central effect of corticosterone. Bechtold et al. [41] found that endogenous corticosterone acts via hindbrain glucocorticoid receptors (GR) to enhance the pressor response to stress in adult BHR males but promotes adaptation in WKY. Moreover, prenatal dexamethasone treatment (a synthetic glucocorticoid analogue) increased baseline arterial pressure selectively in BHR in both sexes, but pCort increased only in female BHR [37]. With respect to our results, we assume that a similar corticosterone-mediated mechanism could be responsible for the differential effects of crowding on BP development in young WKY and BHR females. But to the best of our knowledge, no information is available in the literature on the role of hindbrain GRs in stress-exposed SHR.

In addition to the pressor effects, corticosterone is involved in modulating body mass. A study by Akana et al. [43] revealed the narrow range of pCort (10–75 ng/mL) that is compatible with a normal growth rate. In their study, reduced body weight gain was observed in young normotensive male rats when pCort exceeded this range. Indeed, pCort levels in the above-mentioned interval, together with normal body weight gain, were observed in stressed WKY and control BHR rats in this study, while elevated pCort concentrations in stressed BHR as well as in both SHR groups were associated with reductions in body mass gain. Crowding has also been reported to reduce body weight gain [44] via reduced food intake in both sexes [44, 45], which was also seen in young females in this study (data not shown).

Furthermore, there are studies showing that glucocorticoids may alter vascular function, and hypertension was shown to be the most significant negative side effect of chronic glucocorticoid treatment in humans [46, 47]. Additionally, inhibition of glucocorticoid release prevented acute mental stress-induced endothelial dysfunction [48]. Glucocorticoids were shown to downregulate NO production by limiting tetrahydrobiopterin (BH4) production [49] and eNOS gene transcription [50], which might result in endothelial dysfunction. Interestingly, in this experimental study, crowding did not affect maximal relaxation in any genotype, regardless of the pCort level, but it modified the mechanism of relaxation responses—its NO-dependent and independent components. The most pronounced alterations in the mechanism of vasorelaxation were observed in WKY, without alteration in BP, suggesting successful allostasis [51]. However, the absence of an influence of stress on overall relaxation in BHR (versus control), together with reduced NE-induced constriction, suggests that nonvascular mechanisms are involved in the acceleration of hypertension development seen in this genotype. In contrast, young control SHR females developed endothelial dysfunction, with reductions in both the NO-dependent and NO-independent components of relaxation (versus WKY), and stress failed to modify these changes. A finding of a reduced NO-independent component of ACh-induced relaxation in young SHR females is in agreement with our previous observation in adult SHR males [52]. In contrast, findings of a reduced NO-dependent component of ACh-induced relaxation in young control SHR and BHR females are in opposition with our recent observations of a positive correlation between BP and the NO-dependent component of relaxation in adult male BHR and SHR [52]. Whether this discrepancy results from the animals’ different ages, sexes, or both remains to be elucidated in further studies, yet methodological aspects can be excluded [23] as the same methods were used in both our studies.

Oxidative stress, which seems to play an important role in the development of endothelial dysfunction [23], is another parameter that was shown to be modulated by glucocorticoids [50]. In this study, elevated superoxide concentration in the aorta was observed under control conditions in both genotypes with a predisposition to hypertension; however, it was more pronounced in SHR than in BHR. Regarding crowding stress, it elevated superoxide in WKY, in agreement with studies that found oxidative damage in normotensive rats exposed to chronic stress [22, 53, 54]. Interestingly, crowding stress had no effect in BHR and yet reduced superoxide concentration in SHR versus its respective control group. However, the level of superoxide in stressed SHR was still approximately two-fold higher compared to WKY and BHR under both control and stress conditions. The reason for this difference is unknown but we assume it may result from genotype-related differences in antioxidant defense systems. Indeed, we found elevations in plasma superoxide dismutase (SOD) activity and reduced lipoperoxide formation in blood as well as increased expression of SOD 1 and 2 in the kidneys of both BHR and SHR females exposed to stress, which was not observed in WKY (data not shown). However, neither elevated vascular NO synthase activity, in association with reduced superoxide level, was able to significantly improve NO-dependent relaxation in stressed SHR, which may be related to guanylate cyclase desensitization [55].

Regarding control SHR, despite enormous research, the exact mechanism of initiation of hypertension in this strain is still unclear. Our data suggest that elevated BP might be associated with alterations in corticosterone concentration or signaling and/or increased superoxide levels which might further lead to sympathetic activation and acceleration of the renin-angiotensin-aldosterone system [56, 57] and thus to an accentuated release of reactive oxygen species (ROS). Enormous ROS production can be implicated in the increased release of the endothelium-derived contracting factors, which may play a crucial role in the development of NO-independent endothelial dysfunction in genetic hypertension [58]. Moreover, possible structural changes in the vasculature of SHR and altered cell-to-cell communication may both participate in altered vascular function observed in SHR rats.

All together, these alterations may damage endothelial function, despite elevated vascular NO production, which would lead to increased peripheral resistance and the development of hypertension disease. If such is the case, how might the elevated BP in control BHR be explained when its basal corticosterone level was similar to that in WKY? It might be explained by elevated sensitivity to everyday stressors, which can be associated with transient periods of high corticosterone levels even under control conditions. As these periods were interrupted by periods of relief, the elevation of ROS could be relatively mild. Under such conditions the development of endothelial dysfunction would be delayed while the central effects of corticosterone acting via GRs might be responsible for the mild increase in BP observed in BHR. In addition, disruption or resetting of the baroreflex [42] may also participate in the gradual increase of BP in BHR. In such a situation, exposure of BHR to chronic social stress, associated with long-term HPA activation and imbalance in sympathovagal control [42], could accelerate the increase in BP as was observed in this study. The absence of signs of endothelial dysfunction in young BHR females exposed to crowding might also be explained by the relatively short duration and intensity of the stress used in this study, which may not be sufficient to exceed the adaptive mechanisms protecting vascular function, such as elevated NO production and reduced NE-constriction. Reduced NE-induced constriction in BHR may result from augmented sensitivity and number of β-2 adrenergic receptors due to elevated corticosterone [59] which may blunt α-1 adrenergic receptor-mediated constriction. Yet prolongation of stress could be associated with later development of NO-independent endothelial dysfunction, as we observed previously in WKY males exposed to 12 weeks of crowding [15]. Another possible explanation for the lack of stress-induced endothelial dysfunction is that the increasing estrogenic activity of young females at this age protects them from its development [60, 61].

5. Conclusions

In conclusion, this study resulted in several important findings. First of all, it points out that rats without a predisposition to hypertension were able to adapt to the given stressor via successful allostasis. Second, we showed significantly higher corticosterone and superoxide concentrations in young SHR females, which may play a role in the early development of endothelial dysfunction and hypertension in this strain. Furthermore, this study showed that the genetic predisposition to hypertension in SHR is the dominant factor in hypertension developing and stress did not aggravate the increase in BP under the given conditions. Additionally, we confirmed an elevation in vascular NO production after chronic stress exposure, which can act as an antistress mechanism in young females. However, the most important result of this study is that exposure to stress during a sensitive developmental period (in rats between the fifth and seventh weeks of life) can accelerate the inevitable increase in BP in juvenile females that are the offspring of hypertensive mothers and normotensive fathers. These females were more vulnerable to stress than female offspring of two normotensive or two hypertensive parents. Data suggested that their susceptibility to stress-induced hypertension resulted from the central effects of corticosterone rather than from altered vascular function.

On balance then, this study suggests caution in chronic exposure to stressors in childhood and juvenescence, especially in individuals where one parent suffers from hypertension. Although the progress of hypertension is usually slow and the disease is fully manifested in adulthood, it might originate from stressful environmental conditions in early periods of life.

Conflict of Interests

The authors declare that they have no conflicts of interests.

Authors’ Contribution

Peter Slezak and Angelika Puzserova contributed to the same extent.


The authors thank Mrs. Jana Petova for her excellent technical assistance. This study was supported by Grant nos. VEGA 2/0084/10 and APVV-0523-10. The infrastructure used in this study was partially supported by the Project of “ITMS 26240120020-Establishment of the Centre for the Research on Composite Materials for Structural Engineering and Medical Applications-CEKOMAT II.”


  1. C. N. B. Merz, J. Dwyer, C. K. Nordstrom, K. G. Walton, J. W. Salerno, and R. H. Schneider, “Psychosocial stress and cardiovascular disease: pathophysiological links,” Behavioral Medicine, vol. 27, no. 4, pp. 141–147, 2002. View at: Google Scholar
  2. M. S. Kopp and J. Réthelyi, “Where psychology meets physiology: chronic stress and premature mortality—the Central-Eastern European health paradox,” Brain Research Bulletin, vol. 62, no. 5, pp. 351–367, 2004. View at: Publisher Site | Google Scholar
  3. A. Rosengren, S. Hawken, S. Ôunpuu et al., “Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9438, pp. 953–962, 2004. View at: Publisher Site | Google Scholar
  4. A. Steptoe, A. Rosengren, and P. Hjemdahl, “Introduction to cardiovascular disease, stress and adaptation,” in Stress and Cardiovascular Diseases, P. Hjemdahl, A. Rosengren, and A. Steptoe, Eds., pp. 1–14, Springer, 2012. View at: Google Scholar
  5. M. Esler, N. Eikelis, M. Schlaich et al., “Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 4, pp. 498–502, 2008. View at: Publisher Site | Google Scholar
  6. M. Esler, “The causal role of chronic mental stress in the pathogenesis of essential hypertension,” in Stress and Cardiovascular Disease, P. Hjemdahl, A. Rosengren, and A. Steptoe, Eds., pp. 273–283, Springer, 2012. View at: Google Scholar
  7. F. Sparrenberger, S. C. Fuchs, L. B. Moreira, and F. D. Fuchs, “Stressful life events and current psychological distress are associated with self-reported hypertension but not with true hypertension: results from a cross-sectional population-based study,” BMC Public Health, vol. 8, article 357, 2008. View at: Publisher Site | Google Scholar
  8. F. Sparrenberger, F. T. Cichelero, A. M. Ascoli et al., “Does psychosocial stress cause hypertension? A systematic review of observational studies,” Journal of Human Hypertension, vol. 23, no. 1, pp. 12–19, 2009. View at: Publisher Site | Google Scholar
  9. D. L. Wong, T. C. Tai, D. C. Wong-Faull et al., “Epinephrine: a short- and long-term regulator of stress and development of illness—a potential new role for epinephrine in stress,” Cellular and Molecular Neurobiology, vol. 32, no. 5, pp. 737–748, 2012. View at: Publisher Site | Google Scholar
  10. J. Zicha and J. Kuneš, “Ontogenetic aspects of hypertension development: analysis in the rat,” Physiological Reviews, vol. 79, no. 4, pp. 1227–1282, 1999. View at: Google Scholar
  11. J. Kunes, M. Kadlecova, I. Vaneckova et al., “Critical developmental periods in the pathogenesis of hypertension,” Physiological Research, vol. 61, supplement 1, pp. S9–17, 2012. View at: Google Scholar
  12. J. Kuneš and J. Zicha, “Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view,” Clinical Science, vol. 111, no. 5, pp. 295–305, 2006. View at: Publisher Site | Google Scholar
  13. J. Bugajski, “Social stress adapts signaling pathways involved in stimulation of the hypothalamic-pituitary-adrenal axis,” Journal of Physiology and Pharmacology, vol. 50, no. 3, pp. 367–379, 1999. View at: Google Scholar
  14. J. Djordjević, G. Cvijić, and V. Davidović, “Different activation of ACTH and corticosterone release in response to various stressors in rats,” Physiological Research, vol. 52, no. 1, pp. 67–72, 2003. View at: Google Scholar
  15. A. Puzserova, P. Slezak, P. Balis et al., “Long-term social stress induces nitric oxide-independent endothelial dysfunction in normotensive rats,” Stress, vol. 16, pp. 331–339, 2013. View at: Google Scholar
  16. O. N. Bondarenko, N. A. Bondarenko, I. Y. Malyshev, and E. B. Manukhina, “Antistress effect of nitric oxide,” Biology Bulletin, vol. 28, no. 4, pp. 387–393, 2001. View at: Publisher Site | Google Scholar
  17. N. Toda and M. Nakanishi-Toda, “How mental stress affects endothelial function,” Pflügers Archiv, vol. 462, no. 6, pp. 779–794, 2011. View at: Publisher Site | Google Scholar
  18. I. Bernátová, A. Púzserová, J. Navarová, Z. Csizmadiová, and M. Zeman, “Crowding-induced alterations in vascular system of Wistar-Kyoto rats: role of nitric oxide,” Physiological Research, vol. 56, no. 5, pp. 667–669, 2007. View at: Google Scholar
  19. S. Grunfeld, C. A. Hamilton, S. Mesaros et al., “Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats,” Hypertension, vol. 26, no. 6, pp. 854–857, 1995. View at: Google Scholar
  20. A. Zafir and N. Banu, “Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats,” Stress, vol. 12, no. 2, pp. 167–177, 2009. View at: Publisher Site | Google Scholar
  21. S. Kwiecień, M. W. Pawlik, T. Brzozowski et al., “Nitric oxide (NO)-releasing aspirin and (NO) donors in protection of gastric mucosa against stress,” Journal of Physiology and Pharmacology, vol. 59, no. 2, pp. 103–115, 2008. View at: Google Scholar
  22. E. F. Kamper, A. Chatzigeorgiou, O. Tsimpoukidi et al., “Sex differences in oxidant/antioxidant balance under a chronic mild stress regime,” Physiology and Behavior, vol. 98, no. 1-2, pp. 215–222, 2009. View at: Publisher Site | Google Scholar
  23. I. Bernatova, M. Victoria Conde, J. Kopincova, M. Carmen González, A. Puzserova, and S. M. Arribas, “Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects,” Journal of Hypertension, vol. 27, no. 6, pp. S27–S31, 2009. View at: Publisher Site | Google Scholar
  24. A. M. Dart, X.-J. Du, and B. A. Kingwell, “Gender, sex hormones and autonomic nervous control of the cardiovascular system,” Cardiovascular Research, vol. 53, no. 3, pp. 678–687, 2002. View at: Publisher Site | Google Scholar
  25. O. Semyachkina-Glushkovskaya, T. Anishchenko, S. Kapralov et al., “Sex differences in cardiovascular control by nitric oxide in normotensive and hypertensive rats,” Health, vol. 2, pp. 897–905, 2010. View at: Google Scholar
  26. B. M. Kudielka and C. Kirschbaum, “Sex differences in HPA axis responses to stress: a review,” Biological Psychology, vol. 69, no. 1, pp. 113–132, 2005. View at: Publisher Site | Google Scholar
  27. T. G. Anishchenko, O. V. Glushkovskaya-Semyachkina, V. A. Berdnikova, and T. A. Sindyakova, “Sex-related differences in cardiovascular stress reactivity in healthy and hypertensive rats,” Bulletin of Experimental Biology and Medicine, vol. 143, no. 2, pp. 178–181, 2007. View at: Publisher Site | Google Scholar
  28. M. J. Mulvany, “Procedures for investigation of small vessels using small vessel myograph,” Danish Myo Technology, 16-8-2012, 2004, View at: Google Scholar
  29. F. C. Munhoz, S. R. Potje, A. C. Pereira et al., “Hypotensive and vasorelaxing effects of the new NO-donor [Ru(terpy)(bdq)NO+]3+ in spontaneously hypertensive rats,” Nitric Oxide, vol. 26, no. 2, pp. 111–117, 2012. View at: Publisher Site | Google Scholar
  30. T. G. Guzik and K. M. Channon, “Measurement of vascular reactive oxygen species production by chemiluminescence,” in Hypertension: Methods and Protocols, J. P. Fennell and A. H. Baker, Eds., pp. 73–89, Springer, Humana Press, Totowa, NJ, USA, 2005. View at: Google Scholar
  31. V. Regecova and E. Kellerova, “Effects of urban noise pollution on blood pressure and heart rate in preschool children,” Journal of Hypertension, vol. 13, no. 4, pp. 405–412, 1995. View at: Google Scholar
  32. A. L. Miller, C. Clifford, J. Sturza et al., “Blunted cortisol response to stress is associated with higher body mass index in low-income preschool-aged children,” Psychoneuroendocrinology, vol. 38, pp. 2611–2617, 2013. View at: Google Scholar
  33. R. G. Kuijer and J. A. Boyce, “Emotional eating and its effect on eating behaviour after a natural disaster,” Appetite, vol. 58, no. 3, pp. 936–939, 2012. View at: Publisher Site | Google Scholar
  34. L. Bobrovskaya, D. Beard, E. Bondarenko et al., “Does exposure to chronic stress influence blood pressure in rats?” Autonomic Neuroscience, vol. 177, pp. 217–223, 2013. View at: Google Scholar
  35. B. M. Sweis, K. K. Veverka, E. S. Dhillon et al., “Individual differences in the effects of chronic stress on memory: behavioral and neurochemical correlates of resiliency,” Neuroscience, vol. 246, pp. 142–159, 2013. View at: Google Scholar
  36. T.-L. Sterley, F. M. Howells, and V. A. Russell, “Effects of early life trauma are dependent on genetic predisposition: a rat study,” Behavioral and Brain Functions, vol. 7, article 11, 2011. View at: Publisher Site | Google Scholar
  37. A. G. Bechtold, K. Vernon, T. Hines, and D. A. Scheuer, “Genetic predisposition to hypertension sensitizes borderline hypertensive rats to the hypertensive effects of prenatal glucocorticoid exposure,” Journal of Physiology, vol. 586, no. 2, pp. 673–684, 2008. View at: Publisher Site | Google Scholar
  38. N. Grissom and S. Bhatnagar, “Habituation to repeated stress: get used to it,” Neurobiology of Learning and Memory, vol. 92, no. 2, pp. 215–224, 2009. View at: Publisher Site | Google Scholar
  39. J. G. Tasker and J. P. Herman, “Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis,” Stress, vol. 14, no. 4, pp. 398–406, 2011. View at: Publisher Site | Google Scholar
  40. I. Bernatova, Z. Csizmadiova, J. Kopincova, and A. Puzserova, “Vascular function and nitric oxide production in chronic social-stress-exposed rats with various family history of hypertension,” Journal of Physiology and Pharmacology, vol. 58, no. 3, pp. 487–501, 2007. View at: Google Scholar
  41. A. G. Bechtold, G. Patel, G. Hochhaus, and D. A. Scheuer, “Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 296, no. 5, pp. R1445–R1454, 2009. View at: Publisher Site | Google Scholar
  42. O. Šarenac, M. Lozić, S. Drakulić et al., “Autonomic mechanisms underpinning the stress response in borderline hypertensive rats,” Experimental Physiology, vol. 96, no. 6, pp. 574–589, 2011. View at: Publisher Site | Google Scholar
  43. S. F. Akana, C. S. Cascio, J. Shinsako, and M. F. Dallman, “Corticosterone: narrow range required for normal body and thymus weight and ACTH,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 249, no. 5, pp. R527–R532, 1985. View at: Google Scholar
  44. H. S. Nagaraja and P. S. Jeganathan, “Voluntary alcohol drinking & caloric intake in rats exposed to crowding stress,” Indian Journal of Medical Research, vol. 116, pp. 111–116, 2002. View at: Google Scholar
  45. K. J. Brown and N. E. Grunberg, “Effects of environmental conditions on food consumption in female and male rats,” Physiology and Behavior, vol. 60, no. 1, pp. 293–297, 1996. View at: Publisher Site | Google Scholar
  46. J. E. Goodwin and D. S. Geller, “Glucocorticoid-induced hypertension,” Pediatric Nephrology, vol. 27, no. 7, pp. 1059–1066, 2012. View at: Publisher Site | Google Scholar
  47. C. G. Schnackenberg, M. H. Costell, D. J. Krosky et al., “Chronic inhibition of 11β-hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome,” BioMed Research International, vol. 2013, Article ID 427640, 10 pages, 2013. View at: Publisher Site | Google Scholar
  48. A. J. M. Broadley, A. Korszun, E. Abdelaal et al., “Inhibition of cortisol production with metyrapone prevents mental stress-induced endothelial dysfunction and baroreflex impairment,” Journal of the American College of Cardiology, vol. 46, no. 2, pp. 344–350, 2005. View at: Publisher Site | Google Scholar
  49. W. W. Simmons, D. Ungureanu-Longrois, G. K. Smith, T. W. Smith, and R. A. Kelly, “Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport,” Journal of Biological Chemistry, vol. 271, no. 39, pp. 23928–23937, 1996. View at: Publisher Site | Google Scholar
  50. S. P. Duckles and V. M. Miller, “Hormonal modulation of endothelial NO production,” Pflügers Archiv, vol. 459, no. 6, pp. 841–851, 2010. View at: Publisher Site | Google Scholar
  51. R. A. Sarabdjitsingh, M. Joëls, and E. R. de Kloet, “Glucocorticoid pulsatility and rapid corticosteroid actions in the central stress response,” Physiology and Behavior, vol. 106, no. 1, pp. 73–80, 2012. View at: Publisher Site | Google Scholar
  52. A. Puzserova, J. Kopincova, P. Slezak et al., “Endothelial dysfunction in femoral artery of the hypertensive rats is nitric oxide independent,” Physiological Research, vol. 62, pp. 615–629, 2013. View at: Google Scholar
  53. M. Devaki, R. Nirupama, and H. N. Yajurvedi, “Chronic stress-induced oxidative damage and hyperlipidemia are accompanied by atherosclerotic development in rats,” Stress, vol. 16, pp. 233–243, 2013. View at: Google Scholar
  54. A. Zafir and N. Banu, “Induction of oxidative stress by restraint stress and corticosterone treatments in rats,” Indian Journal of Biochemistry and Biophysics, vol. 46, no. 1, pp. 53–58, 2009. View at: Google Scholar
  55. A. Friebe and D. Koesling, “Regulation of nitric oxide-sensitive guanylyl cyclase,” Circulation Research, vol. 93, no. 2, pp. 96–105, 2003. View at: Publisher Site | Google Scholar
  56. H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama, “The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease,” Pharmacological Reviews, vol. 59, no. 3, pp. 251–287, 2007. View at: Publisher Site | Google Scholar
  57. D. A. Scheuer and A. G. Bechtold, “Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 280, no. 6, pp. R1719–R1726, 2001. View at: Google Scholar
  58. I. Bernatova, “Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence?” BioMed Research International. In press. View at: Google Scholar
  59. A. Jazayeri and W. J. Meyer III, “Glucocorticoid modulation of β-adrenergic receptors of cultured rat arterial smooth muscle cells,” Hypertension, vol. 12, no. 4, pp. 393–398, 1988. View at: Google Scholar
  60. G. S. Ceravolo, F. P. Filgueira, T. J. Costa et al., “Conjugated equine estrogen treatment corrected the exacerbated aorta oxidative stress in ovariectomized spontaneously hypertensive rats,” Steroids, vol. 78, pp. 341–346, 2013. View at: Google Scholar
  61. L. Brandin, G. Bergström, K. Manhem, and H. Gustafsson, “Oestrogen modulates vascular adrenergic reactivity of the spontaneously hypertensive rat,” Journal of Hypertension, vol. 21, no. 9, pp. 1695–1702, 2003. View at: Publisher Site | Google Scholar

Copyright © 2014 Peter Slezak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.